Phase II study of oxaliplatin versus oxaliplatin combined with infusional 5-fluorouracil in hormone refractory metastatic prostate cancer patients

Autor: Droz, J.P., Muracciole, X., Mottet, N., Ould Kaci, M., Vannetzel, J.M., Albin, N., Culine, S., Rodier, J.-M., Misset, J.-L., Mackenzie, S. *, Cvitkovic, E., Benoit, G.
Zdroj: In Annals of Oncology August 2003 14(8):1291-1298
Databáze: ScienceDirect